Sigma-Aldrich Investor Relations
Sigma-Aldrich Investor Home Home Sigma-Aldrich home page

Investor Relations

Corporate Profile

Sigma-Aldrich, a leading Life Science and Technology company focused on enhancing human health and safety, manufactures and distributes 230,000 chemicals, biochemicals and other essential products and 40,000 equipment products to more than 1.4 million customers globally in research and applied labs as well as in industrial and commercial markets.  With three distinct business units – Research, Applied and SAFC Commercial – Sigma-Aldrich is committed to enabling science to improve the quality of life.  The Company operates in 37 countries, has approximately 9,000 employees worldwide and had sales of $2.7 billion in 2013.  For more information about Sigma-Aldrich, please visit its website at

Recent Releases

Nov 10, 2015
Sigma-Aldrich and Merck KGaA, Darmstadt, Germany, Obtain EC Antitrust Approval and Work Toward Closing Planned Acquisition

Nov 4, 2015
Sigma-Aldrich Collaborates with GENEWIZ and Oxford Genetics to Speed Ordering Process for DNA Services

Nov 3, 2015
Sigma-Aldrich (NASDAQ - SIAL) Reports Q3 2015 Sales Of $703 Million And Adjusted Diluted EPS Of $1.00

View all releases »

Featured Documents

© 2015 Sigma-Aldrich Co. Reproduction forbidden without permission.
Sigma-Aldrich brand products are sold exclusively through Sigma-Aldrich, Inc. Best viewed in IE5 or higher